Literature DB >> 1309604

Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay.

J Bukh1, R H Purcell, R H Miller.   

Abstract

We compared four primer sets from conserved regions of the hepatitis C virus (HCV) genome for their ability to detect HCV RNA in a "nested" cDNA polymerase chain reaction assay on sera from 114 anti-HCV antibody-positive individuals from around the world. The different primer sets had equivalent sensitivity, detecting less than 1 chimpanzee ID50 (dose that infects 50%) when tested against reference strain H of HCV. We tested equal amounts of RNA extracted from the serum of each individual with the four primer sets. The set derived from two highly conserved domains within the 5' noncoding (NC) region of the HCV genome, which also share significant similarity with Pestivirus 5' NC sequences, was the most effective at detecting HCV RNA. All samples positive for HCV RNA with any other primer set were also positive with the primer set from the 5' NC region, and the latter was at least 3 times more likely to detect HCV infection than a primer set from within the nonstructural protein 3-like gene region (P less than 0.001). We had no false positive results in greater than 500 negative controls interspersed among the test samples. The 5' NC region primer set detected HCV-specific RNA, verified by high-stringency Southern blot hybridization and DNA sequencing, in 100% of 15 acute and 33 chronic non-A, non-B hepatitis patients from the United States, Europe, and Asia and 10 hepatocellular carcinoma patients from Africa and Asia that tested negative for the hepatitis B virus-encoded surface antigen. In conclusion, use of an appropriate primer set is crucial for detecting HCV RNA in the serum of infected individuals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309604      PMCID: PMC48201          DOI: 10.1073/pnas.89.1.187

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

Authors:  P Farci; H J Alter; D Wong; R H Miller; J W Shih; B Jett; R H Purcell
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

3.  Hepatitis C virus: evidence for sexual transmission.

Authors:  R S Tedder; R J Gilson; M Briggs; C Loveday; C H Cameron; J A Garson; G E Kelly; I V Weller
Journal:  BMJ       Date:  1991-06-01

4.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

5.  Hepatitis B viral DNA in infected human liver and in hepatocellular carcinoma.

Authors:  R H Miller; S C Lee; Y F Liaw; W S Robinson
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

6.  The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers.

Authors:  K Takeuchi; Y Kubo; S Boonmar; Y Watanabe; T Katayama; Q L Choo; G Kuo; M Houghton; I Saito; T Miyamura
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

7.  Infantile gastroenteritis associated with excretion of pestivirus antigens.

Authors:  R Yolken; E Dubovi; F Leister; R Reid; J Almeido-Hill; M Santosham
Journal:  Lancet       Date:  1989-03-11       Impact factor: 79.321

8.  A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan.

Authors:  Y Kubo; K Takeuchi; S Boonmar; T Katayama; Q L Choo; G Kuo; A J Weiner; D W Bradley; M Houghton; I Saito
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

9.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

10.  Frequent detection of hepatitis C virus US strain in Japanese hemophiliacs.

Authors:  M Hijikata; N Kato; S Mori; Y Ootsuyama; M Nakagawa; T Sugimura; S Ohkoshi; H Kojima; T Meguro; M Taki
Journal:  Jpn J Cancer Res       Date:  1990-12
View more
  59 in total

Review 1.  Laboratory assays for diagnosis and management of hepatitis C virus infection.

Authors:  Sandra S Richter
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Clinician's guide to diagnostic tests for hepatitis C virus infections.

Authors:  G Delage
Journal:  Can J Infect Dis       Date:  1993-05

3.  Evaluation of commercially available and in-house reverse transcription-PCR assays for detection of hepatitis G virus or GB virus C.

Authors:  X Forns; D Tan; H J Alter; R H Purcell; J Bukh
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

4.  Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypes.

Authors:  L Krekulova; V Rehak; A E Wakil; E Harris; L W Riley
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

5.  Correlation Study Between HCV Genotypes Distribution Pattern and Viral Load in a Tertiary Care Hospital in Kolkata, India.

Authors:  Debojyoti Bhattacharjee; Kheya Mukherjee; Goutam Chakroborti; Ranadeep Ghosh; Nabarun Mandal; Mohua Bose
Journal:  J Clin Diagn Res       Date:  2015-05-01

6.  Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.

Authors:  R Ray; A Khanna; L M Lagging; K Meyer; Q L Choo; R Ralston; M Houghton; P R Becherer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

Review 7.  Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation.

Authors:  G M Woolf; L M Petrovic; S E Rojter; F G Villamil; L Makowka; L G Podesta; L S Sher; L Memsic; J M Vierling
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

8.  HCV antibody response and genotype distribution in different areas and races of China.

Authors:  Leili Jia; Jiyun Yu; Jinliang Yang; Hongbin Song; Xuelin Liu; Yong Wang; Yuanyong Xu; Chuanfu Zhang; Yanwei Zhong; Qiao Li
Journal:  Int J Biol Sci       Date:  2009-06-13       Impact factor: 6.580

9.  HCV infection in patients with primary defects of immunoglobulin production.

Authors:  I Quinti; F Pandolfi; R Paganelli; D el Salman; A Giovannetti; R Rosso; A Oliva; L Rainaldi; F Aiuti
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

10.  Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.

Authors:  R Nagayama; F Tsuda; H Okamoto; Y Wang; T Mitsui; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.